Suzon-S 500mg/500mg Injection
By Suzon-S
Rx
1 Powder for Injection in a Vial

Composition
Cefoperazone(500mg) + Sulbactam(500mg)

Manufacturer - Osper Formulations Pvt Ltd
WORK: 134-B EPIP PHASE 1, Jharmajri, Baddi, District- Solan (H.P.) , India.

Expires on or after
September, 2025

liver
Limited information is currently available regarding the use of Suzon-S 500mg/500mg Injection in individuals with liver disease. It is imperative to seek guidance from your healthcare provider before using this medication, especially if you have a history of liver issues. An in-depth consultation with your doctor can help determine the appropriateness of Suzon-S 500mg/500mg Injection in relation to your liver health. Your healthcare provider will be able to assess your specific situation and provide personalized advice tailored to your medical needs.

kidney
Limited data exists on the use of Suzon-S 500mg/500mg Injection in patients with kidney disease. Please seek advice from your doctor regarding kidney-related concerns before using this medication.

alcohol
When taking Suzon-S 500mg/500mg Injection, avoid alcohol to prevent symptoms like flushing, increased heart rate, nausea, chest pain, and low blood pressure (Disulfiram reaction).

driving
It is not clear if Suzon-S 500mg/500mg Injection affects driving ability. Avoid driving if you have symptoms that impact concentration and reaction time.

pregnancy
Suzon-S 500mg/500mg Injection is generally considered safe to use during pregnancy. Animal studies show minimal adverse effects on the developing baby, but human studies are limited.

breastfeeding
Suzon-S 500mg/500mg Injection is considered safe to use while breastfeeding. Research shows it is unlikely to pass into breastmilk in harmful amounts. It is generally safe for both the mother and the baby during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹125
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025